Deutsche Bank Upgrades Celgene (CELG) to Buy; Sees Big Opportunity for Apremilast
Tweet Send to a Friend
Deutsche Bank upgrades Celgene (Nasdaq: CELG) from Hold to Buy, moving its price target from $105 up to $143.
This article: 173 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 173 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
